Cytosorbents Q3 Earnings Report: Analyzing the Miss on GAAP EPS and Revenue

Thursday, 14 March 2024, 21:09

Cytosorbents published its Q3 earnings report, revealing a GAAP EPS of -$0.64, falling short by $0.02, and revenue of $31.09M, missing by $6.4M. The financial results indicate a quarter below market expectations, prompting investors to reevaluate their positions in the company.
LivaRava Finance Meta Image
Cytosorbents Q3 Earnings Report: Analyzing the Miss on GAAP EPS and Revenue

Cytosorbents Q3 Earnings Report

Cytosorbents announced their financial performance for the third quarter, highlighting a GAAP EPS of -$0.64 and a revenue of $31.09M. The results fell short in comparison to the consensus estimates, missing the EPS by $0.02 and revenue by $6.4M.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe